Iovance Biotherapeutics logo
Iovance Biotherapeutics IOVA
$ 6.9 -5.61%
report update icon

Quarterly report 2026-Q3
added 11-05-2026

Iovance Biotherapeutics Total Assets | IOVA

Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.
Main categories of assets
Current assets (used within one year):
  • Cash and cash equivalents
  • Accounts receivable (amounts owed by customers)
  • Inventory of goods, raw materials, and supplies
  • Short-term investments
Non-current assets (used for more than one year):
  • Fixed assets (buildings, machinery, equipment)
  • Intangible assets (brands, patents, software)
  • Long-term investments
  • Goodwill (reputational value from mergers)

Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.

Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.

Annual Total Assets Iovance Biotherapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
913 M 910 M 780 M 664 M 777 M 768 M 345 M 481 M 155 M 172 M 106 M 46.5 M 19.9 M 29.4 K 568 K 1.46 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
913 M 29.4 K 384 M

Quarterly Total Assets Iovance Biotherapeutics

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
991 M 916 M 926 M 913 M 905 M 907 M 967 M 910 M 991 M 964 M 870 M 780 M 852 M 757 M 825 M 664 M 546 M - 701 M 777 M 829 M 853 M 751 M 768 M 768 M 768 M 768 M 345 M 345 M 345 M 462 M 481 M 271 M 285 M 307 M 155 M 174 M 138 M 155 M 172 M 182 M 194 M 101 M 106 M 112 M 115 M 114 M 46.5 M 17.4 M 18.5 M 18.1 M 19.9 M 19.9 M 19.9 M 19.9 M 29.4 K 29.4 K 29.4 K 29.4 K 568 K 568 K 568 K 568 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
991 M 29.4 K 426 M

Total Assets of other stocks in the Biotechnology industry

Issuer Total Assets Price % 24h Market Cap Country
Cerus Corporation Cerus Corporation
CERS
222 M $ 1.86 -2.37 % $ 355 M usaUSA
Beam Therapeutics Beam Therapeutics
BEAM
1.48 B $ 20.87 -0.36 % $ 2.06 B usaUSA
Inhibrx Inhibrx
INBX
308 M $ 68.81 -7.43 % $ 3.24 B usaUSA
Scholar Rock Holding Corporation Scholar Rock Holding Corporation
SRRK
404 M $ 48.09 -4.54 % $ 5.52 B usaUSA
Revolution Medicines Revolution Medicines
RVMD
2.35 B $ 161.01 0.99 % $ 30.6 B usaUSA
Entera Bio Ltd. Entera Bio Ltd.
ENTX
16 M $ 3.29 0.15 % $ 152 M israelIsrael
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc.
FLXN
252 M - - $ 459 M usaUSA
Legend Biotech Corporation Legend Biotech Corporation
LEGN
1.73 B $ 15.21 -5.53 % $ 5.61 B usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
152 M $ 2.04 -0.73 % $ 281 M usaUSA
China SXT Pharmaceuticals China SXT Pharmaceuticals
SXTC
34.8 M $ 2.67 2.9 % $ 1.81 M chinaChina
Krystal Biotech Krystal Biotech
KRYS
1.33 B $ 308.83 -2.21 % $ 8.94 B usaUSA
Kura Oncology Kura Oncology
KURA
738 M $ 6.91 -6.05 % $ 606 M usaUSA
Inhibikase Therapeutics Inhibikase Therapeutics
IKT
181 M $ 1.31 0.38 % $ 129 M usaUSA
Protara Therapeutics Protara Therapeutics
TARA
209 M $ 2.28 -5.21 % $ 97.7 M usaUSA
Heron Therapeutics Heron Therapeutics
HRTX
256 M $ 0.25 -5.3 % $ 41.7 M usaUSA
Inovio Pharmaceuticals Inovio Pharmaceuticals
INO
74.3 M $ 1.76 2.63 % $ 82.5 M usaUSA
Corvus Pharmaceuticals Corvus Pharmaceuticals
CRVS
71.1 M $ 9.66 -3.5 % $ 763 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
105 M $ 2.66 -0.37 % $ 32.8 M usaUSA
Heat Biologics, Inc. Heat Biologics, Inc.
HTBX
124 M - -5.76 % $ 99.8 M usaUSA
Innoviva Innoviva
INVA
1.64 B $ 18.42 0.03 % $ 1.24 B usaUSA
BioCardia BioCardia
BCDA
3.41 M $ 0.77 -0.08 % $ 5.13 M usaUSA
Bio-Techne Corporation Bio-Techne Corporation
TECH
2.59 B $ 72.69 -0.01 % $ 11.3 B usaUSA
Kindred Biosciences, Inc. Kindred Biosciences, Inc.
KIN
95.8 M - 0.11 % $ 419 M usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
46 M $ 1.52 -8.16 % $ 9.72 B australiaAustralia
Shineco, Inc. Shineco, Inc.
TYHT
79.1 M - -3.90 % $ 97.2 M chinaChina
ORIC Pharmaceuticals ORIC Pharmaceuticals
ORIC
409 M $ 7.34 -4.68 % $ 644 M usaUSA
Certara Certara
CERT
1.56 B $ 10.56 -1.12 % $ 1.69 B usaUSA
Intec Pharma Ltd Intec Pharma Ltd
NTEC
20.9 M - -12.45 % $ 17.7 M israelIsrael
Anika Therapeutics Anika Therapeutics
ANIK
190 M $ 13.26 -0.15 % $ 190 M usaUSA
Aprea Therapeutics Aprea Therapeutics
APRE
15.9 M $ 0.23 -52.81 % $ 1.5 M usaUSA
Galectin Therapeutics Galectin Therapeutics
GALT
19.5 M $ 2.68 -4.63 % $ 171 M usaUSA
Processa Pharmaceuticals Processa Pharmaceuticals
PCSA
7.81 M $ 1.59 -5.92 % $ 2.08 M usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
837 M $ 63.61 -2.11 % $ 6.61 B usaUSA
Progenity, Inc. Progenity, Inc.
PROG
154 M - -3.47 % $ 164 M usaUSA
Genprex Genprex
GNPX
10.2 M $ 1.46 -12.87 % $ 1.36 M usaUSA
Strongbridge Biopharma plc Strongbridge Biopharma plc
SBBP
121 M - 1.52 % $ 136 M usaUSA
Nektar Therapeutics Nektar Therapeutics
NKTR
280 M $ 30.23 -7.1 % $ 510 M usaUSA
Innate Pharma S.A. Innate Pharma S.A.
IPHA
62.7 M $ 0.87 -7.57 % $ 77.9 M franceFrance
Seneca Biopharma, Inc. Seneca Biopharma, Inc.
SNCA
13 M - -1.19 % $ 28.7 M usaUSA
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
7.59 B $ 60.42 -1.64 % $ 11.6 B usaUSA
Matinas BioPharma Holdings Matinas BioPharma Holdings
MTNB
7.21 M $ 0.75 -9.23 % $ 4.11 M usaUSA
Enanta Pharmaceuticals Enanta Pharmaceuticals
ENTA
276 M $ 7.6 -4.82 % $ 220 M usaUSA
Milestone Pharmaceuticals Milestone Pharmaceuticals
MIST
114 M $ 0.38 -5.66 % $ 40.4 M canadaCanada
Lipocine Lipocine
LPCN
17 M $ 1.47 -2.33 % $ 8.01 M usaUSA
Seres Therapeutics Seres Therapeutics
MCRB
138 M $ 1.25 -6.02 % $ 11.1 M usaUSA
Oramed Pharmaceuticals Oramed Pharmaceuticals
ORMP
231 M $ 3.58 -2.98 % $ 148 M israelIsrael
Madrigal Pharmaceuticals Madrigal Pharmaceuticals
MDGL
1.26 B $ 378.19 -4.68 % $ 8.48 B usaUSA
CEL-SCI Corporation CEL-SCI Corporation
CVM
28.2 M $ 1.2 -18.37 % $ 9.62 M usaUSA
Inventiva S.A. Inventiva S.A.
IVA
119 M $ 3.14 -9.13 % $ 188 M franceFrance